Yoshihisa Tanada

Novel Design of Nonpeptide AVP V₂Receptor Agonists:  Structural Requirements for an Agonist Having 1-(4-Aminobenzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepine as a Template

Kazumi Kondo, Hidenori Ogawa, Tomoichi Shinohara et al. · Journal of Medicinal Chemistry · 2000 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Stereoselective Synthesis of 2,3-dihydroxy-4-dimethylamino-5-methoxypentanoic acid, a fragment of calyculins ------- determination of the absolute configuration of calyculins

Yasumasa Hamada, Yoshihisa Tanada, Fumiaki Yokokawa et al. · Tetrahedron Letters · 1991 · 50 citations

Natural Sciences, Biochemistry, Chemistry +7

Characterization of Orally Active Nonpeptide Vasopressin V₂ Receptor Agonist. Synthesis and Biological Evaluation of Both the (5<i>R</i>)- and (5<i>S</i>)-Enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin- 5-yl]-<i>N</i>-isopropylacetamide

Kazumi Kondo, Keizo Kan, Yoshihisa Tanada et al. · Journal of Medicinal Chemistry · 2002 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Characterization of a novel nonpeptide vasopressin V₂‐agonist, OPC‐51803, in cells transfected human vasopressin receptor subtypes

Shigeki Nakamura, Yoshitaka Yamamura, S. Itoh et al. · British Journal of Pharmacology · 2000 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Synthesis and Absolute Configuration of Nocardione A and B, Furano-o-naphthoquinone-Type Metabolites of Nocardia sp. with Antifungal, Cytotoxic, and Enzyme Inhibitory Activities

Yoshihisa Tanada, Kenji Mori · European Journal of Organic Chemistry · 2001 · 15 citations

Pharmacy, Chemistry, Medicinal Chemistry +10